Capital Markets Issues Faced by European Companies in the Age of COVID-19

Overview

Please join Goodwin’s Life Sciences group for a weekly webinar series that aims to provide a multidisciplinary outlook on top-of-mind issues facing European life sciences companies in the era of COVID-19. 

This webinar series will be hosted and moderated by Goodwin Life Sciences Corporate partner Robert Puopolo. In each webinar, he will be joined by Goodwin colleagues and other market leaders to delve into the pertinent capital markets, regulatory, IP, licensing and cross-border M&A issues affecting European life sciences companies. 

This Session

Please join Goodwin’s Life Sciences Corporate partner, Robert Puopolo in conversation with Stifel Financial Corporation’s Managing Director for Healthcare Investment Banking, Nicholas Moore, Nasdaq’s Director EMEA, Asaf Homossany, and ICR Capital’s Managing Director, Co-Head of Capital Markets, Lee Stettner, as they discuss issues faced by European life sciences companies when accessing the U.S. capital markets. The topics will include IPOs, follow-on offerings and private placements, as well as issues relating to transaction structures, investor relations, SRO rules and geographic concerns.

Request an Invitation